McElhaugh Michael J.
CIK 0001635326
Interim President & CEODirector
Filings
5
Latest Feb 19, 2025
Issuers covered
1
Showing
5 of 5
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -7.1% | -7.1% | -0.3% | -13.9% |
| 90 days | 2 | 0% | -8.5% | -8.5% | -4.5% | -12.6% |
| 180 days | 2 | 50% | -28.9% | -28.9% | +0.6% | -58.4% |
| 365 days | 2 | 0% | -26.6% | -26.6% | -15.5% | -37.8% |
Issuers
Companies where McElhaugh Michael J. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 5 | Feb 19, 2025 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|